Carvedilol (Carvil (6.25 mg)) is an alpha- and beta-blocker, prescribed for heart failure and high blood pressure. It relaxes blood vessels and slowing heart rate to improve blood flow and decreases ...

Endoscopic band ligation (EBL) and nonselective β-blockade are two effective strategies in the primary prevention of variceal bleeding. Meta-analyses have shown an advantage of EBL over propranolol ...

A low-dose regimen of the blood pressure medication carvedilol demonstrated safety and efficacy in improving heart health of childhood cancer survivors, according to results of a multicenter phase 2b ...

Carvedilol has the capacity to block both the β-1 and β-2 adrenergic receptors, as well as the α-1 receptors. There is evidence to indicate that full adrenergic blockade by carvedilol improves ...

The disparity in the results between the Metoprolol in Dilated Cardiomyopathy Trial and MERIT-HF raised the possibility that only extended- release metoprolol succinate is effective in treating heart ...

London, UK - The Carvedilol or Metoprolol European Trial (COMET) trial, showing improved survival with carvedilol over metoprolol, has now been published in the July 5, 2003 issue of the Lancet. The ...

Please provide your email address to receive an email when new articles are posted on . Researchers found a significantly higher mean number of asthma exacerbations among patients with heart failure ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The use of ...